Skip to main content
Premium Trial:

Request an Annual Quote

FDA Grants Emergency Use Authorizations for Altona, Diatherix Eurofins Coronavirus Tests

NEW YORK — The US Food and Drug Administration on Wednesday granted separate Emergency Use Authorizations for PCR-based SARS-CoV-2 tests developed by Altona Diagnostics and Diatherix Eurofins.

Altona's RealStar SARS-CoV-2 RT-PCR Kit US is designed to detect viral nucleic acid in nasopharyngeal swabs, oropharyngeal swabs, anterior nasal swabs, mid-turbinate nasal swabs, nasal washes, and nasal aspirates. It runs on any authorized RT-PCR instrument and may be performed by labs CLIA-certified for high-complexity testing.

Diatherix's SARS-CoV-2 Assay is designed to detect viral nucleic acid in nasal swabs, nasopharyngeal swabs/wash, oropharyngeal swabs/throat swabs, bronchial aspirates, or sputum. It has been validated for use with Thermo Fisher Scientific's KingFisher Flex System using either Qiagen's ClearMag or Omega Bio-tek's Mag-Bind extraction reagents. The test can also be performed on the Thermo Fisher's Applied Biosystems GeneAmp 9700 or Veriti 96-well Thermal Cycler, the FDA said.

Diatherix's test may only be performed by its own laboratory.

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more